RT Journal Article
SR Electronic
T1 Single-cell RNA sequencing reveals the distinctive roles of CD4<sup>+</sup> and CD8<sup>+</sup> T cells in autoimmune uveitis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.28.22282728
DO 10.1101/2022.11.28.22282728
A1 Kang, Hao
A1 Sun, Hongjian
A1 Yang, Yang
A1 Shu, Minglei
A1 Wei, Yunbo
A1 Zhang, Yu
A1 Yu, Di
A1 Tao, Yong
YR 2022
UL http://medrxiv.org/content/early/2022/12/06/2022.11.28.22282728.abstract
AB Uveitis is a common cause of blindness and classified as infectious or non-infectious types. Non-infectious uveitis is often secondary to systemic autoimmune diseases, with Behçet’s disease (BD) and Vogt-Koyanagi-Harada disease (VKHD) as the two most common causes. Uveitis in BD and VKHD often show similar clinical manifestations, but the underlying immunopathogenesis remains unclear. We collected immune cell infiltrates in aqueous humour of BD and VKHD uveitis patients and analysed them by single-cell RNA paired with T cell receptor (TCR) sequencing. T cells were found as the dominant immune cell infiltration. Intriguingly, a majority of CD4+ in T cell infiltrates was only observed in VKHD but not in BD. In agreement with this discrepancy between VKHD and BD, T cell clonality analysis and Clonotype Neighbour Graph Analysis (CoNGA) also revealed a selective expansion of pro-inflammatory CD4+ T cell clones in VKHD. In contrast, BD showed a selective expansion of pro-inflammatory CD8+ T cell clones. Our study reveals distinct immunopathogenesis of uveitis driven by CD4+ T cells in VKHD and by CD8+ T cells in BD, and therefore suggests differential approaches for their diagnosis and therapy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Natural Science Foundation of China (Grant No.81900849, 82070948, 82071792), Beijing Talent Project (No.2020027), Shunyi District "Beijing Science and technology achievements transformation coordination and service platform" construction fund (SYGX202010) and Capital Health Development Scientific Research Project Grant (to Y.T.). Natural Science Foundation of Shandong Province (Major Basic Program, ZR2020ZD41 to M.S.). Australian National Health Medical Research Council Investigator Fellowship (GNT2009554) and Bellberry-Viertel Senior Medical Research Fellowship (to D.Y.) and The University of Queensland Postgraduate Scholarship (to H.S.)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Beijing Chaoyang Hospital gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets during this study are available at the Science DataBase: https://www.scidb.cn/s/bAF7fe. Codes are available at https://github.com/HongjianSun/Uveitis-project